Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
Author(s):
Samuel A.L. Hall, Gareth S. Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John S. Lubel, Amanda J Nicoll, Simone I. Strasser, William Sievert, Paul V. Desmond, Meng C. Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Kathy Jackson, Margaret Littlejohn, D. Scott Bowden, Stephen A. Locarnini, Kumar Visvanathan, Alexander J Thompson
Details:
Alimentary Pharmacology and Therapeutics, Volume 56, Issue 2, 2022-07-01
Article Link: Click here
Affiliations:
- University of Melbourne
- The University of Sydney
- Monash University
- La Trobe University
- Royal Melbourne Hospital
- Royal Prince Alfred Hospital
- St. Vincent's Hospital Melbourne
- Austin Health
- St. Vincent's Hospital Sydney
- Monash Health
- Concord Repatriation General Hospital
- Eastern Health
- Alfred Health
- Bankstown-Lidcombe Hospital
- Liverpool Hospital

